Analyst Reco. PDS Biotechnology Corporation

Equities

PDSB

US70465T1079

Real-time Estimate Cboe BZX Other stock markets 01:10:18 2024-06-05 pm EDT			5-day change	1st Jan Change
2.945 ^USD	+1.55%		-0.34%	-40.64%

May. 15	PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 10	NetScientific says PDS Biotech's Versamune meets endpoints	AN

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating	Mar. 28	MT
Oppenheimer Adjusts PDS Biotechnology Price Target to $20 From $23, Maintains Outperform Rating	Nov. 15	MT
Oppenheimer Adjusts PDS Biotechnology Price Target to $23 From $24, Maintains Outperform Rating	23-08-15	MT
PDS Biotechnology Corporation Announces Interim Data Demonstrates 12-Month Survival Rate of 87% with PDS0101 in Combination with Keytruda (Pembrolizumab) for Head and Neck Cancer Patients	23-05-25	CI
HC Wainwright Adjusts Price Target on PDS Biotechnology to $21 From $15, Maintains Buy Rating	23-01-03	MT
B. Riley Lifts Price Target on PDS Biotechnology to $12 From $10, Cites Higher Probability of Success for Triplet Regimen; Buy Kept	22-12-29	MT
Chardan Increases Price Target on PDS Biotechnology to $16 From $15, Keeps Buy Rating	22-11-15	MT
B. Riley Securities Starts PDS Biotechnology at Buy With $10 Price Target	22-11-01	MT
Alliance Global Adjusts Price Target on PDS Biotechnology to $16 From $18, Reiterates Buy Rating	22-05-16	MT
PDS BIOTECHNOLOGY : HC Wainwright Adjusts Price Target on PDS Biotechnology to $15 From $20, Maintains Buy Rating	21-08-12	MT
PDS BIOTECHNOLOGY : Cantor Fitzgerald Starts PDS Biotechnology at Overweight With $25 Price Target	21-06-28	MT
PDS BIOTECHNOLOGY : Alliance Global Partners Adjusts Price Target on PDS Biotechnology to $18 From $6.50, Maintains Buy Rating	21-06-09	MT
PDS BIOTECHNOLOGY : Chardan Adjusts Price Target on PDS Biotechnology to $15 From $11, Maintains Buy Rating	21-06-09	MT
PDS BIOTECHNOLOGY : Oppenheimer Adjusts PDS Biotechnology's Price Target to $25 From $12, Maintains Outperform Rating	21-06-09	MT
PDS BIOTECHNOLOGY : HC Wainwright Adjusts PDS Biotechnology's PT to $20 from $8, Keeps Buy Rating	21-06-02	MT
PDS BIOTECHNOLOGY : Chardan Capital Adjusts Price Target on PDS Biotechnology to $11 From $10, Maintains Buy Rating	21-05-20	MT
PDS BIOTECHNOLOGY : Oppenheimer Adjusts PDS Biotechnology PT to $12 From $7, Maintains Outperform Rating	21-03-19	MT
PDS BIOTECHNOLOGY : HC Wainwright Adjusts PDS Biotechnology's Price Target to $8 from $6, Keeps Buy Rating	21-03-19	MT
PDS BIOTECHNOLOGY : Oppenheimer Initiates Coverage on PDS Biotechnology With Outperform Rating, $7 Price Target	20-12-04	MT
PDS BIOTECHNOLOGY : HC Wainwright Upgrades PDS Biotechnology to Buy From Neutral; Price Target is $6	20-11-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. PDS Biotechnology Corporation

Equities

PDSB

US70465T1079

Analyst Reco.

Filters